Symbols / AMST
AMST Chart
About
Amesite Inc., a technology company, engages in the marketing and development of B2C and B2B AI-driven solutions in the United States. Its products include Amesite Engage, that leverages proprietary AI infrastructure, offering cutting-edge applications that cater to both individual and professional needs; and NurseMagic, mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situation. Amesite Inc. was founded in 2017 and is headquartered in Detroit, Michigan.
Fundamentals
Scroll to Statements| Sector | Technology | Industry | Software - Application | Market Cap | 8.37M |
| Enterprise Value | 7.20M | Income | -2.96M | Sales | 288.80K |
| Book/sh | 0.33 | Cash/sh | 0.26 | Dividend Yield | — |
| Payout | 0.00% | Employees | 6 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 28.98 | P/B | 5.55 | P/C | — |
| EV/EBITDA | -2.46 | EV/Sales | 24.94 | Quick Ratio | 2.39 |
| Current Ratio | 2.72 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.60 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | 7.47% | Earnings | 2023-02-10 15:00 | ROA | -89.28% |
| ROE | -214.99% | ROIC | — | Gross Margin | 100.00% |
| Oper. Margin | -6.90% | Profit Margin | 0.00% | Shs Outstand | 4.57M |
| Shs Float | 3.04M | Short Float | 3.40% | Short Ratio | 3.81 |
| Short Interest | — | 52W High | 4.78 | 52W Low | 1.76 |
| Beta | 1.11 | Avg Volume | 197.09K | Volume | 16.52K |
| Target Price | — | Recom | None | Prev Close | $1.80 |
| Price | $1.83 | Change | 1.67% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$1.83
Latest analyst target
3. DCF / Fair value
$-4.67
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.83
Low
—
High
—
Mean
—
- New AI medical record system enters booming post-acute care market - Stock Titan Fri, 19 Dec 2025 08
- Amesite Inc. Launches NurseMagicâ„¢ EMR, Expanding AI Solutions in Post-Acute Care Market | AMST Stock News - Quiver Quantitative Fri, 19 Dec 2025 08
- Ex-Dividend Reminder: Banco Latinoamericano de Comercio Exterior, Manulife Financial and Standard and Poors Global - Nasdaq Mon, 23 Feb 2026 15
- AMST Stock Flying High: Too Late to Buy? - StocksToTrade Fri, 19 Dec 2025 08
- Insider Trends: Does IMMP have declining or rising EPS - Insider Selling & Weekly Breakout Watchlists - baoquankhu1.vn Wed, 25 Feb 2026 21
- This New Product Launch Is Lifting Amesite Shares Premarket — Here’s What Investors Are Watching - Stocktwits Fri, 19 Dec 2025 08
- 12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session - Benzinga hu, 05 Feb 2026 08
- 63% Revenue Surge: Amesite's AI Platform NurseMagic Tackles $200B Post-Acute Care Documentation Crisis - Stock Titan hu, 11 Sep 2025 07
- Top movers in Friday's after hours session - ChartMill Fri, 19 Dec 2025 08
- Amesite Announces Quarterly Revenue Increase of 2.4x in 10-Q Filing - Yahoo Finance Fri, 16 May 2025 07
- Amesite Stock Surges on AI-Powered NurseMagic Growth: What’s Driving the Hype? - RagingBull hu, 11 Sep 2025 07
- AMST’s Unexpected Surge: A Deeper Dive - StocksToTrade hu, 11 Sep 2025 07
- T Offshore Inc. align with a passive investing strategy - Market Risk Summary & Real-Time Sentiment Analysis - mfd.ru Sat, 21 Feb 2026 20
- AMST Stock Price and Chart — NASDAQ:AMST - TradingView Sat, 26 Sep 2020 00
- Amesite (AMST) Stock Price, News & Analysis - MarketBeat Fri, 02 Oct 2020 10
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 41322 | — | — | Stock Award(Grant) at price 0.00 per share. | LOSH JOHN MICHAEL | Director | — | 2025-03-07 00:00:00 | I |
| 1 | 41322 | — | — | Stock Award(Grant) at price 0.00 per share. | OMENN GILBERT S | Director | — | 2025-03-07 00:00:00 | I |
| 2 | 41322 | — | — | Stock Award(Grant) at price 0.00 per share. | PARMER GEORGE | Director | — | 2025-03-07 00:00:00 | D |
| 3 | 41322 | — | — | Stock Award(Grant) at price 0.00 per share. | BREWER BARBIE | Director | — | 2025-03-07 00:00:00 | D |
| 4 | 36630 | nan | — | — | LOSH JOHN MICHAEL | Director | — | 2025-01-16 00:00:00 | I |
| 5 | 36630 | nan | — | — | OMENN GILBERT S | Director | — | 2025-01-16 00:00:00 | I |
| 6 | 36630 | nan | — | — | PARMER GEORGE | Director | — | 2025-01-16 00:00:00 | D |
| 7 | 36630 | nan | — | — | BREWER BARBIE | Director | — | 2025-01-16 00:00:00 | D |
| 8 | 3333 | 9999.0 | — | Purchase at price 3.00 per share. | OMENN GILBERT S | Director | — | 2025-01-07 00:00:00 | I |
| 9 | 83333 | 249999.0 | — | Purchase at price 3.00 per share. | PARMER GEORGE | Director | — | 2025-01-07 00:00:00 | D |
Financials
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -3.08M | -4.05M | -3.47M | -8.18M |
| TotalUnusualItems | -90.87K | 0.00 | ||
| TotalUnusualItemsExcludingGoodwill | -90.87K | 0.00 | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -3.62M | -4.40M | -4.15M | -9.06M |
| ReconciledDepreciation | 433.80K | 533.67K | 682.48K | 875.60K |
| EBITDA | -3.17M | -4.05M | -3.47M | -8.18M |
| EBIT | -3.60M | -4.58M | -4.15M | -9.06M |
| NetInterestIncome | 77.40K | 176.47K | 71.20K | 9.23K |
| InterestExpense | 0.00 | 1.62K | 12.63K | 3.61M |
| InterestIncome | 77.40K | 176.47K | 72.82K | 9.23K |
| NormalizedIncome | -3.53M | -4.40M | -4.15M | -9.06M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -3.62M | -4.40M | -4.15M | -9.06M |
| TotalExpenses | 3.71M | 4.75M | 5.07M | 9.75M |
| TotalOperatingIncomeAsReported | -3.60M | -4.58M | -4.22M | -9.06M |
| DilutedAverageShares | 3.53M | 2.54M | 2.47M | 1.94M |
| BasicAverageShares | 3.53M | 2.54M | 2.47M | 1.94M |
| DilutedEPS | -1.03 | -1.73 | -1.68 | -4.67 |
| BasicEPS | -1.03 | -1.73 | -1.68 | -4.67 |
| DilutedNIAvailtoComStockholders | -3.62M | -4.40M | -4.15M | -9.06M |
| NetIncomeCommonStockholders | -3.62M | -4.40M | -4.15M | -9.06M |
| NetIncome | -3.62M | -4.40M | -4.15M | -9.06M |
| NetIncomeIncludingNoncontrollingInterests | -3.62M | -4.40M | -4.15M | -9.06M |
| NetIncomeContinuousOperations | -3.62M | -4.40M | -4.15M | -9.06M |
| PretaxIncome | -3.62M | -4.40M | -4.15M | -9.06M |
| OtherIncomeExpense | -90.87K | -1.62K | -12.63K | |
| OtherNonOperatingIncomeExpenses | -1.62K | -12.63K | ||
| SpecialIncomeCharges | -90.87K | 0.00 | ||
| ImpairmentOfCapitalAssets | 90.87K | 0.00 | ||
| NetNonOperatingInterestIncomeExpense | 77.40K | 176.47K | 71.20K | 9.23K |
| InterestExpenseNonOperating | 0.00 | 1.62K | 12.63K | 3.61M |
| InterestIncomeNonOperating | 77.40K | 176.47K | 72.82K | 9.23K |
| OperatingIncome | -3.60M | -4.58M | -4.22M | -9.06M |
| OperatingExpense | 3.71M | 4.75M | 5.07M | 9.75M |
| ResearchAndDevelopment | 691.15K | 1.07M | 1.52M | 3.06M |
| SellingGeneralAndAdministration | 3.02M | 3.67M | 3.55M | 6.69M |
| SellingAndMarketingExpense | 545.03K | 763.91K | 1.05M | 1.51M |
| GeneralAndAdministrativeExpense | 2.48M | 2.91M | 2.49M | 5.18M |
| OtherGandA | 2.48M | 2.91M | 2.49M | 5.18M |
| TotalRevenue | 110.46K | 166.88K | 845.01K | 697.00K |
| OperatingRevenue | 110.46K | 166.88K | 845.01K | 697.00K |
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| OrdinarySharesNumber | 4.57M | 2.54M | 2.54M | 2.17M |
| ShareIssued | 4.57M | 2.54M | 2.54M | 2.17M |
| TangibleBookValue | 2.21M | 1.87M | 5.31M | 7.07M |
| InvestedCapital | 2.74M | 2.52M | 6.08M | 8.14M |
| WorkingCapital | 2.08M | 1.71M | 5.22M | 6.98M |
| NetTangibleAssets | 2.21M | 1.87M | 5.31M | 7.07M |
| CommonStockEquity | 2.74M | 2.52M | 6.08M | 8.14M |
| TotalCapitalization | 2.74M | 2.52M | 6.08M | 8.14M |
| TotalEquityGrossMinorityInterest | 2.74M | 2.52M | 6.08M | 8.14M |
| StockholdersEquity | 2.74M | 2.52M | 6.08M | 8.14M |
| RetainedEarnings | -41.45M | -37.83M | -33.43M | -29.28M |
| AdditionalPaidInCapital | 44.19M | 40.35M | 39.51M | 37.41M |
| CapitalStock | 458.00 | 255.00 | 255.00 | 217.00 |
| CommonStock | 458.00 | 255.00 | 255.00 | 217.00 |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 358.60K | 798.47K | 265.33K | 748.11K |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentLiabilities | 358.60K | 798.47K | 265.33K | 748.11K |
| CurrentDeferredLiabilities | 36.74K | 0.00 | 53.96K | 342.67K |
| CurrentDeferredRevenue | 36.74K | 0.00 | 53.96K | 342.67K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 243.20K | 655.27K | 64.50K | 174.06K |
| PayablesAndAccruedExpenses | 78.65K | 143.19K | 146.87K | 231.38K |
| CurrentAccruedExpenses | 53.24K | 94.28K | 76.80K | 109.09K |
| Payables | 25.41K | 48.91K | 70.07K | 122.28K |
| AccountsPayable | 25.41K | 48.91K | 70.07K | 122.28K |
| TotalAssets | 3.10M | 3.31M | 6.35M | 8.88M |
| TotalNonCurrentAssets | 663.24K | 809.61K | 867.41K | 1.15M |
| OtherNonCurrentAssets | 100.00K | 100.00K | ||
| GoodwillAndOtherIntangibleAssets | 523.80K | 644.83K | 778.45K | 1.07M |
| OtherIntangibleAssets | 523.80K | 644.83K | 778.45K | 1.07M |
| NetPPE | 39.44K | 64.78K | 88.97K | 87.19K |
| AccumulatedDepreciation | -142.91K | -117.56K | -92.21K | -66.86K |
| GrossPPE | 182.34K | 182.34K | 181.18K | 154.05K |
| MachineryFurnitureEquipment | 182.34K | 182.34K | 181.18K | 154.05K |
| CurrentAssets | 2.43M | 2.50M | 5.48M | 7.73M |
| OtherCurrentAssets | 94.10K | 403.49K | 106.68K | 560.08K |
| RestrictedCash | 100.00K | 100.00K | ||
| PrepaidAssets | 560.08K | 299.39K | ||
| Receivables | 6.34K | 30.06K | 15.00K | 14.54K |
| AccountsReceivable | 6.34K | 30.06K | 15.00K | 14.54K |
| CashCashEquivalentsAndShortTermInvestments | 2.33M | 2.07M | 5.26M | 7.16M |
| CashAndCashEquivalents | 2.33M | 2.07M | 5.26M | 7.16M |
| Line Item | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| FreeCashFlow | -2.83M | -3.19M | -3.65M | -7.43M |
| IssuanceOfDebt | 0.00 | |||
| IssuanceOfCapitalStock | 3.10M | 0.00 | 1.85M | 3.87M |
| CapitalExpenditure | -378.30K | -375.87K | -396.03K | -711.62K |
| EndCashPosition | 2.43M | 2.17M | 5.26M | 7.16M |
| BeginningCashPosition | 2.17M | 5.36M | 7.06M | 10.71M |
| ChangesInCash | 262.40K | -3.19M | -1.79M | -3.56M |
| FinancingCashFlow | 3.10M | 0.00 | 1.85M | 3.87M |
| CashFlowFromContinuingFinancingActivities | 3.10M | 0.00 | 1.85M | 3.87M |
| NetCommonStockIssuance | 3.10M | 0.00 | 1.85M | 3.87M |
| CommonStockIssuance | 3.10M | 0.00 | 1.85M | 3.87M |
| NetIssuancePaymentsOfDebt | 0.00 | |||
| NetShortTermDebtIssuance | 0.00 | |||
| ShortTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | -378.30K | -375.87K | -396.03K | -711.62K |
| CashFlowFromContinuingInvestingActivities | -378.30K | -375.87K | -396.03K | -711.62K |
| NetIntangiblesPurchaseAndSale | -768.90K | |||
| PurchaseOfIntangibles | -768.90K | |||
| NetPPEPurchaseAndSale | 0.00 | -1.17K | -27.12K | -16.57K |
| PurchaseOfPPE | 0.00 | -1.17K | -27.12K | -16.57K |
| CapitalExpenditureReported | -378.30K | -374.70K | -368.91K | -695.05K |
| OperatingCashFlow | -2.46M | -2.81M | -3.25M | -6.72M |
| CashFlowFromContinuingOperatingActivities | -2.46M | -2.81M | -3.25M | -6.72M |
| ChangeInWorkingCapital | 515.13K | 221.27K | -29.83K | -122.37K |
| ChangeInOtherWorkingCapital | 36.74K | -53.96K | -288.71K | 9.47K |
| ChangeInPayablesAndAccruedExpense | 145.28K | 587.10K | -194.06K | 92.28K |
| ChangeInAccruedExpense | 168.77K | 608.26K | -141.85K | 14.36K |
| ChangeInPayable | -23.49K | -21.16K | -52.21K | 77.92K |
| ChangeInAccountPayable | -23.49K | -21.16K | -52.21K | 77.92K |
| ChangeInPrepaidAssets | 309.39K | -296.81K | 453.40K | -260.69K |
| ChangeInReceivables | 23.72K | -15.06K | -455.00 | 36.58K |
| ChangesInAccountReceivables | 23.72K | -15.06K | -455.00 | 36.58K |
| OtherNonCashItems | -200.00K | 71.94K | 148.95K | 4.62M |
| StockBasedCompensation | 226.05K | 834.47K | 179.53K | 1.44M |
| AssetImpairmentCharge | 90.87K | 0.00 | 0.00 | |
| DepreciationAmortizationDepletion | 433.80K | 533.67K | 682.48K | 875.60K |
| DepreciationAndAmortization | 433.80K | 533.67K | 682.48K | 875.60K |
| AmortizationCashFlow | 408.45K | 508.32K | ||
| AmortizationOfIntangibles | 408.45K | 508.32K | ||
| Depreciation | 25.35K | 25.35K | ||
| OperatingGainsLosses | 95.98K | |||
| GainLossOnInvestmentSecurities | 95.98K | |||
| NetIncomeFromContinuingOperations | -3.62M | -4.40M | -4.15M | -9.06M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for AMST
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|